Suppr超能文献

新型冠状病毒(SARS-CoV-2)IgM/IgG 抗体检测可在三次核酸检测阴性后确认感染。

SARS-CoV-2 lgM/lgG antibody detection confirms the infection after three negative nucleic acid detection.

机构信息

Department of Cardiology, Zhongshan Hospital, Shanghai Institute of Cardiovascular Diseases, Fudan University, Shanghai, China.

Department of Infectious Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.

出版信息

J Cell Mol Med. 2020 Jul;24(14):8262-8265. doi: 10.1111/jcmm.15275. Epub 2020 May 19.

Abstract

An ongoing outbreak of viral pneumonia was caused by a novel coronavirus in China in 2019. By March 19, over 200 thousand confirmed cases of SARS-CoV-2 infection and over 9000 deaths have been reported throughout the world. For this infectious disease, nucleic acid detection is still the gold standard for pathogenic detection. However, nucleic acid detection takes a long time and has relatively high "false negative"; therefore, we need urgently a convenient and accurate detection method to make up for this deficiency. In this article, we will show such technical characteristics of lgM/lgG serum antibody detection, compared with nucleic acid detection.

摘要

2019 年中国发生了新型冠状病毒引起的病毒性肺炎疫情。截至 2020 年 3 月 19 日,全球已报告超过 20 万例新型冠状病毒感染确诊病例,死亡人数超过 9000 例。对于这种传染病,核酸检测仍然是病原检测的金标准。然而,核酸检测耗时较长,且具有相对较高的“假阴性”;因此,我们迫切需要一种方便、准确的检测方法来弥补这一不足。本文将展示 lgM/lgG 血清抗体检测与核酸检测相比的技术特点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebcf/7348156/bbb523a080df/JCMM-24-8262-g001.jpg

相似文献

3
The Promise and Peril of Antibody Testing for COVID-19.新冠病毒抗体检测的前景与风险
JAMA. 2020 May 19;323(19):1881-1883. doi: 10.1001/jama.2020.6170.

引用本文的文献

4
Research progress in laboratory detection of SARS-CoV-2.SARS-CoV-2 实验室检测的研究进展。
Ir J Med Sci. 2022 Apr;191(2):509-517. doi: 10.1007/s11845-021-02604-4. Epub 2021 Mar 24.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验